• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Resolution of pretibial myxedema with teprotumumab in a patient with Graves disease.

作者信息

Varma Aakaash, Rheeman Charles, Levitt Jacob

机构信息

College of Medicine, SUNY Downstate Health Sciences University, Brooklyn, New York.

Department of Dermatology, The Mount Sinai Hospital, New York, New York.

出版信息

JAAD Case Rep. 2020 Sep 15;6(12):1281-1282. doi: 10.1016/j.jdcr.2020.09.003. eCollection 2020 Dec.

DOI:10.1016/j.jdcr.2020.09.003
PMID:33294564
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7701010/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cc4b/7701010/913e47f5445b/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cc4b/7701010/913e47f5445b/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cc4b/7701010/913e47f5445b/gr1.jpg

相似文献

1
Resolution of pretibial myxedema with teprotumumab in a patient with Graves disease.用替普罗单抗治疗格雷夫斯病患者的胫前黏液性水肿消退情况。
JAAD Case Rep. 2020 Sep 15;6(12):1281-1282. doi: 10.1016/j.jdcr.2020.09.003. eCollection 2020 Dec.
2
Graves' disease complicated by concurrent thyroid eye disease and pretibial myxedema successfully treated with teprotumumab.用替普罗单抗成功治疗并发甲状腺眼病和胫前黏液性水肿的格雷夫斯病。
Clin Case Rep. 2022 Nov 19;10(11):e6621. doi: 10.1002/ccr3.6621. eCollection 2022 Nov.
3
Orbital decompression in Graves' ophthalmopathy associated with pretibial myxedema.格雷夫斯眼病合并胫前黏液性水肿的眼眶减压术
J Endocrinol Invest. 1993 Jun;16(6):433-7. doi: 10.1007/BF03348875.
4
Pretibial myxedema in a euthyroid patient: a case report.一名甲状腺功能正常患者的胫前黏液性水肿：病例报告
Thyroid Res. 2021 Mar 1;14(1):4. doi: 10.1186/s13044-021-00096-z.
5
Pretibial myxedema as the initial manifestation of Graves' disease.胫前黏液性水肿作为格雷夫斯病的初始表现。
J Eur Acad Dermatol Venereol. 2002 Jul;16(4):380-3. doi: 10.1046/j.1468-3083.2002.00567.x.
6
TSH and TSH receptor antibody-binding sites in fibroblasts of pretibial myxedema are related to the extracellular domain of entire TSH receptor.胫前黏液性水肿成纤维细胞中的促甲状腺激素（TSH）和TSH受体抗体结合位点与完整TSH受体的细胞外结构域相关。
Clin Immunol Immunopathol. 1994 Apr;71(1):113-20. doi: 10.1006/clin.1994.1059.
7
Pretibial mucin. Histologic patterns and clinical correlation.胫前黏液。组织学模式与临床相关性。
Arch Dermatol. 1993 Sep;129(9):1152-6. doi: 10.1001/archderm.129.9.1152.
8
Elephantiasic pretibial myxedema in a patient with graves disease that resolved after 131I treatment.Graves 病患者的 elephantiasic 胫前黏液性水肿，131I 治疗后消退。
Clin Nucl Med. 2014 Aug;39(8):758-9. doi: 10.1097/RLU.0000000000000459.
9
Euthyroid pretibial myxedema.甲状腺功能正常的胫前黏液性水肿
Am J Med. 1987 Feb;82(2):318-20. doi: 10.1016/0002-9343(87)90077-5.
10
Pretibial myxedema and high-dose intravenous immunoglobulin treatment.胫前黏液性水肿与大剂量静脉注射免疫球蛋白治疗
Thyroid. 1994 Winter;4(4):399-408. doi: 10.1089/thy.1994.4.399.

引用本文的文献

1
Rapid response of thyroid eye disease, peripheral edema, and acropathy to teprotumumab infusion.甲状腺眼病、外周水肿和肢端病对替普罗单抗输注的快速反应。
Am J Ophthalmol Case Rep. 2024 Mar 2;34:102031. doi: 10.1016/j.ajoc.2024.102031. eCollection 2024 Jun.
2
Teprotumumab for Treatment of Pretibial Myxedema.替普罗单抗治疗胫前黏液性水肿
JCEM Case Rep. 2023 Jan 23;1(1):luac037. doi: 10.1210/jcemcr/luac037. eCollection 2023 Jan.
3
[An integrated approach to the treatment of pretibial myxedema based on pulse therapy with prednisolone and electrical neuromyostimulation (FREMS-therapy) in a patient with Graves' disease and thyroid eye disease].

本文引用的文献

1
Teprotumumab for the Treatment of Active Thyroid Eye Disease.特罗特鲁单抗治疗活动性甲状腺眼病。
N Engl J Med. 2020 Jan 23;382(4):341-352. doi: 10.1056/NEJMoa1910434.
2
Electrosurgical debulking of pretibial myxedema of the foot.足部胫前黏液性水肿的电外科减容术。
Dermatol Online J. 2019 Feb 15;25(2):13030/qt4hb7q330.
3
Pretibial myxedema: pathophysiology and treatment options.胫前黏液性水肿：病理生理学与治疗选择
[基于泼尼松龙脉冲疗法和电神经肌肉刺激（FREMS疗法）对一名患有格雷夫斯病和甲状腺眼病患者的胫前黏液性水肿进行综合治疗]
Probl Endokrinol (Mosk). 2023 Aug 30;69(4):32-37. doi: 10.14341/probl12888.
4
Dermatologic manifestations of thyroid disease: a literature review.甲状腺疾病的皮肤表现：文献综述。
Front Endocrinol (Lausanne). 2023 May 12;14:1167890. doi: 10.3389/fendo.2023.1167890. eCollection 2023.
5
Graves' disease complicated by concurrent thyroid eye disease and pretibial myxedema successfully treated with teprotumumab.用替普罗单抗成功治疗并发甲状腺眼病和胫前黏液性水肿的格雷夫斯病。
Clin Case Rep. 2022 Nov 19;10(11):e6621. doi: 10.1002/ccr3.6621. eCollection 2022 Nov.
6
Thyroid dermopathy responds to teprotumumab therapy.甲状腺皮肤病对替普罗图单抗治疗有反应。
Endocrinol Diabetes Metab Case Rep. 2022 Mar 1;2022. doi: 10.1530/EDM-21-0201.
7
Therapeutic IGF-I receptor inhibition alters fibrocyte immune phenotype in thyroid-associated ophthalmopathy.治疗性 IGF-I 受体抑制可改变甲状腺相关眼病中的成纤维细胞免疫表型。
Proc Natl Acad Sci U S A. 2021 Dec 28;118(52). doi: 10.1073/pnas.2114244118.
8
Infusion Center Guidelines for Teprotumumab Infusions: Informed Consent, Safety, and Management of Side Effects.输液中心特罗特单抗输注指南：知情同意、安全性和副作用管理。
J Infus Nurs. 2021;44(6):331-338. doi: 10.1097/NAN.0000000000000446.
9
A case of pretibial myxedema treated with teprotumumab.1例用替普罗单抗治疗的胫前黏液性水肿病例。
JAAD Case Rep. 2021 Sep 1;16:134-136. doi: 10.1016/j.jdcr.2021.08.026. eCollection 2021 Oct.
10
Insulin-Like Growth Factor Pathway and the Thyroid.胰岛素样生长因子通路与甲状腺。
Front Endocrinol (Lausanne). 2021 Jun 4;12:653627. doi: 10.3389/fendo.2021.653627. eCollection 2021.
Am J Clin Dermatol. 2005;6(5):295-309. doi: 10.2165/00128071-200506050-00003.
4
Dermopathy of Graves' disease (pretibial myxedema): long-term outcome.格雷夫斯病的皮肤病变（胫前黏液性水肿）：长期预后
J Clin Endocrinol Metab. 2002 Feb;87(2):438-46. doi: 10.1210/jcem.87.2.8220.